Track the Ayala Pharmaceuticals, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Ayala Pharmaceuticals, Inc. has published 8 insider filings. Market capitalisation: €777.3bn. The latest transaction was filed on 12 February 2024 (Levée d'options). Among the most active insiders: Israel Biotech Fund I, L.P.. The full history is openly available.
8
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ayala Pharmaceuticals, Inc. Strong Buy (bullish), based on 41 analysts. Average price target: US$584.24.
28Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 9,739 of 25,791 companies
58.2
score / 100
Value
38
Quality
78
FCF yld0.2%
Earn yld0.8%
EV/EBITDA·
ROE40%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.